PCI/Certain Assets of Wasdell
Transaction details
The proposed acquisition by Millmount Healthcare Limited (t/a PCI Pharma Services) of certain assets of Wasdell Europe Limited has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:9 June 2024
- Publication date:9 April 2026
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of pharmaceuticals - C.21
- Simplified merger:Yes
- Outcome:Cleared
Documents
M.23.034 DeterminationPDF | 167 KBM.23.034 Determination PDF | 167 KB - Opens in new window
Timetable
Parties Involved
Wasdell Europe Limited
Wasdell Europe Limited (""Wasdell"") offers supply chain services in respect of pharmaceutical products. Wasdell operates across multiple sites in Europe and ships to over 47 countries globally.
PCI Pharma Services Group
Millmount Healthcare Limited is a company in the PCI Pharma Services Group (""PCI Group""). PCI Group is a contract development and manufacturing organisation (""CDMO"") which is headquartered in Pennsylvania, USA, and operates globally. PCI Group offers the full suite of drug development and manufacturing services to the pharmaceutical industry. In the State, PCI Group offers CDMO services from two good manufacturing practices (GMP) facilities located in Drogheda, County Louth, and Stamullen, County Meath.
Contacts
- Louis O'Carroll louisocarroll@ccpc.ie
